Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05403541 |
|---|---|
| Brief Title: | Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis |
| First Submitted : | May 26, 2022 |
| First Submitted that Met QC Criteria : | May 26, 2022 |
| First Posted : | June 3, 2022 |
| Last Update Submitted that Met QC Criteria : | January 2, 2024 |
| Last Update Posted : | January 5, 2024 |